GSK plc
13 holdingsFiling period: 2026-06-30Current AUM: $570.5Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Crispr Therapeutics AG | 3.22M | $175.7M | $175.7M | 30.79% | -- | 2026-06-30 |
| 2 | — | Wave Life Sciences Ltd | 18.25M | $106.0M | $106.0M | 18.58% | -- | 2026-06-30 |
| 3 | VIR | Vir Biotechnology Inc | 8.55M | $87.1M | $91.8M | 16.10% | -- | 2026-06-30 |
| 4 | BNTX | Biontech SE | 889.8K | $82.8M | $81.1M | 14.22% | -- | 2026-06-30 |
| 5 | IDYA | Ideaya Biosciences Inc | 1.33M | $49.7M | $47.1M | 8.26% | -- | 2026-06-30 |
| 6 | CYTK | Cytokinetics Inc | 340.4K | $29.0M | $21.8M | 3.82% | -- | 2026-06-30 |
| 7 | LYEL | Lyell Immunopharma Inc | 1.51M | $21.3M | $14.7M | 2.57% | -- | 2026-06-30 |
| 8 | SPRO | Spero Therapeutics Inc | 9.19M | $20.3M | $11.2M | 1.97% | -- | 2026-06-30 |
| 9 | NKTX | Nkarta Inc | 3.15M | $8.9M | $5.5M | 0.96% | -- | 2026-06-30 |
| 10 | FULC | Fulcrum Therapeutics Inc | 1.79M | $6.5M | $6.6M | 1.16% | -- | 2026-06-30 |
| 11 | BCYC | Bicycle Therapeutics PLC | 1.53M | $6.5M | $5.5M | 0.97% | -- | 2026-06-30 |
| 12 | CVRX | Cvrx Inc | 1.01M | $5.2M | $1.4M | 0.25% | -- | 2026-06-30 |
| 13 | RGNX | Regenxbio Inc | 271.5K | $3.3M | $2.0M | 0.35% | -- | 2026-06-30 |
← Scroll →